Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. - Wikidata - wikimedia - TriplyDB

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q42713874

about

Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy The organic anion transporter (OAT) family: a systems biology perspective Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia.Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.Inherited genetic variation in childhood acute lymphoblastic leukemia.Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.What do drug transporters really do?Pharmacogenetics of childhood acute lymphoblastic leukemia.New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition.Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Advances and challenges in hereditary cancer pharmacogenetics.MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia.Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.SLC19A1 hot spot for MTX plasma concentration.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis.Association between SLC19A1 Gene Polymorphism and High Dose Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukaemia and Non Hodgkin Malignant Lymphoma: Introducing a Haplotype based Approach.Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.

P2860

Q26786582-4E51F74D-1644-423B-80CF-84ACB95F30A4 Q28083449-D44FF4B3-68A2-44B4-B3D9-59AF9B054D76 Q28085671-9F964438-5373-4BBD-9A44-9C836FF9C4B3 Q28538292-4EDF67E7-A4A5-45DB-A7AF-4DCF54042BAD Q28540685-44D11E15-41BC-4019-AA12-7375B35093D8 Q33632120-A2152DE1-7312-47F6-962F-92CA7217827E Q33914131-35B46D27-E8A6-41DB-A748-A0F732F31F25 Q34065294-ACCDADDA-6B57-4AD6-9C1F-AF6136D6A3C3 Q35784497-ED0C7E65-117B-4FB0-B64F-7CB843FD11EE Q36250282-8E0B443C-03C6-4B6A-84A8-48864B7C19A8 Q36571217-3DDDAB56-1D57-4F83-9A66-E1A3551D2E09 Q38243175-9B57B6E5-37A6-46CA-AC17-56F095EE0162 Q38266172-9DFF7527-D548-4911-B29C-676B54EFC50B Q38506522-0322B012-6872-48F7-A72A-825BE72B060F Q38888350-F79DB283-ED92-4170-B1A3-130494507485 Q38888369-8945AC72-5322-422E-85D9-44342BB4F399 Q38895172-C6644E3D-2DE8-4A5E-9E04-9240487523AE Q38948499-CA968E10-FBA3-4DE5-8F8B-6E58CE965671 Q39230513-5C190E93-5499-491A-935D-5EAAE3D5A61F Q42706096-514455A2-F386-4532-9FFD-3C7E1189889F Q47310338-92A12EAC-3A92-4627-BF23-9F7C7A7CBE7E Q47592832-A3B827AA-5286-45B8-93CB-2286C78F2DA7 Q47608710-04C4F9FF-A257-4C72-8D95-B3B33D1F5728 Q48331843-B3ABDC6D-8B90-4FC1-91F5-3851212A264B Q49486006-23004331-2DA6-47E1-B336-E29FF0197725 Q49703642-4C2B1603-0D64-4EA0-B4F1-9C84C9EA9441 Q55518023-C78DF030-D85E-451E-816D-4B333BC53288

P2860

Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.

http://www.wikidata.org/entity/Q42713874

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@en

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@nl

type

label

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@en

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@nl

prefLabel

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@en

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@nl

P1433

Q42713874-7A80E871-52B7-417F-A7C9-CCA058600582

P1476

Q42713874-FEA883DB-6DDD-4C35-A27E-7952E0C1BD97

P2093

Q42713874-0D2B193D-DBC9-4816-AEBC-EBEF709DF479

Q42713874-4BE108BD-ACBD-48D1-9076-F980EE7B7EB5

Q42713874-5A65C890-40C8-4DB4-9334-00458FBA2AFA

Q42713874-66883315-EDF0-417E-8FAC-D8DB07ECAFD9

Q42713874-73FCF128-0E2D-4259-A328-984FE40C1F5E

Q42713874-74F7F21E-1243-467D-8772-479C00799270

Q42713874-A92724C0-3183-4FD4-BCF3-7D833279F053

Q42713874-FF48CA39-DAAC-4269-8DDC-FDC82BD9AF33

P304

Q42713874-38F7CE51-6A1C-4C2F-87DD-32B5F5AD2A1A

P31

Q42713874-A209F227-E064-4DCD-9690-B03E06C7FE70

P356

Q42713874-525C58B2-911B-43FF-B35D-17F14CBF95C1

P433

Q42713874-32B290F6-E1D4-492F-B105-3E90BF658986

P478

Q42713874-AA743250-D8F3-4122-818F-0BD7BBB373CA

P577

Q42713874-4180E5AE-475B-4CFB-87BE-1C43AA2073B1

P698

Q42713874-0C478B56-6A84-41B7-B499-648D618A3174

P921

Q42713874-2C5C6A9A-E613-44CB-B8FB-E5AE9B5AE0CE

P356

FPC.0B013E32835C3B24

P1433

Pharmacogenetics and Genomics

P1476

Polymorphisms in the methotrex ...... acute lymphoblastic leukemia.

@en

P2093

Africa Garcia-Orad

http://www.w3.org/2001/XMLSchema#string

Aurora Navajas

http://www.w3.org/2001/XMLSchema#string

Elixabet Lopez-Lopez

http://www.w3.org/2001/XMLSchema#string

Javier Ballesteros

http://www.w3.org/2001/XMLSchema#string

José Sanchez de Toledo

http://www.w3.org/2001/XMLSchema#string

Maria A Piñan

http://www.w3.org/2001/XMLSchema#string

Nagore Garcia de Andoin

http://www.w3.org/2001/XMLSchema#string

Purificacion Garcia-Miguel

http://www.w3.org/2001/XMLSchema#string

P304

53-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FPC.0B013E32835C3B24

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23222202

http://www.w3.org/2001/XMLSchema#string

P921